Literature DB >> 29876595

[Tapering of antidementia drugs, antidepressants and antipsychotics in elderly patients : When possible, when not?]

K Hager1, T Temps2, O Krause3,4.   

Abstract

BACKGROUND: Antidementia drugs, antidepressants and antipsychotics are among the most frequently prescribed medication in old and multimorbid patients. Due to side effects (e. g. prolonged QTc interval) in emergency medicine/intensive care unit or patients' wishes the question is often raised whether these drugs can be stopped and how this may be done. ANTIDEMENTIA DRUGS: If the cognition is stable under antidementia drugs or if the patient is in favour of the medication, it should be continued. After stopping antidementia drugs there may be a deterioration of cognitive function in the following 2-3 months. This should be discussed with the patient and the relatives/caregiver. ANTIDEPRESSANTS: In case of only slight or reactive depressive mood antidepressants should be tapered. The dose should be reduced over a period of at least 4 weeks. A sudden stop may cause a withdrawal syndrome with flu-like symptoms, fatigue, tremor, insomnia, anxiety or confusion. In severe depressive episodes there is a high risk of relapse; therefore deprescribing should only be done after a stable remission of 4-9 months. ANTIPSYCHOTICS: Antipsychotics in dementia or nursing home patients as well as in cases of delirium should be tapered, whereby confusion may increase again. When antipsychotics were prescribed because of hallucinations or severe psychosis, they should not be reduced or only with great caution.

Entities:  

Keywords:  Antidepressants; Antipsychotics; Cholinesterase inhibitors; Deprescribing

Mesh:

Substances:

Year:  2018        PMID: 29876595     DOI: 10.1007/s00063-018-0451-9

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  20 in total

1.  Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.

Authors:  Giovanni A Fava; Alessia Gatti; Carlotta Belaise; Jenny Guidi; Emanuela Offidani
Journal:  Psychother Psychosom       Date:  2015-02-21       Impact factor: 17.659

2.  Antidepressant drug prescribing among elderly subjects: a population-based study.

Authors:  Mauro Percudani; Corrado Barbui; Ida Fortino; Lorenzo Petrovich
Journal:  Int J Geriatr Psychiatry       Date:  2005-02       Impact factor: 3.485

Review 3.  Antipsychotic discontinuation in patients with dementia: a systematic review and meta-analysis of published randomized controlled studies.

Authors:  Yi-Ju Pan; Chi-Shin Wu; Susan Shur-Fen Gau; Hung-Yu Chan; Sube Banerjee
Journal:  Dement Geriatr Cogn Disord       Date:  2013-10-19       Impact factor: 2.959

4.  Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry.

Authors:  Marit Stordal Bakken; Anders Engeland; Lars B Engesæter; Anette Hylen Ranhoff; Steinar Hunskaar; Sabine Ruths
Journal:  Age Ageing       Date:  2013-02-24       Impact factor: 10.668

Review 5.  Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.

Authors:  Tom Declercq; Mirko Petrovic; Majda Azermai; Robert Vander Stichele; An I M De Sutter; Mieke L van Driel; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

Review 6.  Antidepressant discontinuation syndrome.

Authors:  Christopher H Warner; William Bobo; Carolynn Warner; Sara Reid; James Rachal
Journal:  Am Fam Physician       Date:  2006-08-01       Impact factor: 3.292

7.  Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts.

Authors:  Nathan Herrmann; Sandra E Black; Abby Li; Krista L Lanctôt
Journal:  Int Psychogeriatr       Date:  2010-09-20       Impact factor: 3.878

8.  Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Authors:  Philip S Wang; Sebastian Schneeweiss; Jerry Avorn; Michael A Fischer; Helen Mogun; Daniel H Solomon; M Alan Brookhart
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

9.  Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample.

Authors:  Meredith G Harris; Philip M Burgess; Jane Pirkis; Dan Siskind; Tim Slade; Harvey A Whiteford
Journal:  Aust N Z J Psychiatry       Date:  2011-03       Impact factor: 5.744

Review 10.  Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis.

Authors:  Corrado Barbui; Andrea Cipriani; Vikram Patel; José L Ayuso-Mateos; Mark van Ommeren
Journal:  Br J Psychiatry       Date:  2011-01       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.